Black FridayFino al 70% in meno
Axsome Therapeutics, Inc.

$AXSM on POSSIBLE PLUMMETS

Di moannana
AXSM clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system, it is accelerating the completion of the ADVANCE-1 Phase 2/3 trial of AXS-05 in patients with Alzheimer’s disease agitation to ensure the safety of this vulnerable patient population during the COVID-19 pandemic. i expect that this end of the month its increasing thoroughly. Are you guys ready to get through resistance? why not?
AXSMBeyond Technical AnalysisdijTechnical IndicatorsNasdaq Composite Index CFDSPX (S&P 500 Index)Trend AnalysisVIX CBOE Volatility Index
moannana

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.